ニュース

製品
IFU
EN-jp
EN-jp
ホーム>ニュース

抗菌性中枢静脈カテーテルの紹介

2022-07-28
LEPU
抗菌性中枢静脈カテーテルの紹介

Lepu's Antimicrobial Central Venous Catheter is the first medicated central venous catheter market in China. Since its official launch in 2008, it has been used in millions of clinical cases.



Why It Is Recommended To Use Antimicrobial Central Venous Catheter?

In clinical practice, 中央静脈カテーテルキット is commonly used to rescue critically ill patients with severe shock, dehydration, blood loss, and hypovolemia. Monitoring of central venous pressure can guide clinicians in diagnosing and treating patients, so it is often necessary to retain or prolong the indwelling time of the catheter. 


However, the operation time of central venous puncture is short, the patient's body resistance is low, immunity is weak, and trauma is large. With the widespread use of central venous catheters, the consequent infection rate has increased significantly, and the mortality rate of patients has increased. Clinically, central venous catheters have been listed as a common source of infection, so the choice of an Antimicrobial Central Venous Catheter with a bacteriostatic effect can reduce the incidence of infection in patients.


antimicrobial-central-venous-cather-1.jpg



Lepu医療抗菌中枢静脈カテーテルの利点と利点

The disposable Antimicrobial Central Venous Catheter produced by Lepu 医療機器メーカー is based on the traditional central venous catheter and is coated with two antibiotics, rifampicin and minocycline hydrochloride. Among them, rifampicin is a semi-synthetic broad-spectrum antibacterial drug of rifampicin. It has an inhibitory effect on aerobic gram-positive bacteria and aerobic gram-negative bacteria. Minocycline Hydrochloride is a semi-synthetic tetracycline broad-spectrum antibiotic with high efficacy and long-term effect. It has an inhibitory effect on Staphylococcus aureus, Streptococcus, etc., and Gram-negative bacteria. Combining these two drugs produces a complementary antibacterial effect, which can achieve an excellent antibacterial effect. It has been documented that the drug CVC can reduce the incidence of CRABSI by 90%. 


Lepu Medical's クリティカルケア制品 like the Antimicrobial Central Venous Catheter is available in various sizes and is suitable for different types of patients, providing more options for doctors. The connection between the catheter and the extension tube adopts the patented technology, which has solved the leakage and seepage problems of similar products on the market.



薬用中枢静脈カテーテルの臨床使用は、患者の感染の発生率を大幅に減らすことができます。これは、感染性合併症や不必要な医学的紛争を防ぐための新しい予防策でもあります。 Lepuによって製造された抗菌中枢静脈カテーテルは、優れた設計、安全性、有効性、広い抗菌スペクトル、長い抗菌時間、アレルギー反応がないという利点があり、全身性抗生物質の適用サイクルを減らすことができ、高い臨床応用価値を持っています。



より多くの情報のため:https://en.lepumedical.com/products/safecath-plus-antimicrobial-central-venous-catheter-kit/


送信